The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a ...

Marketed as a potential breakthrough for presbyopia — a common age-related vision issue that makes it difficult to see up ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Last week, controversy over the claims over the prowess of eye drops prescribed for presbyopia (progressive loss of the near focusing ability of the eye due to ageing), led to the Central Drugs ...

Instead, we will focus on the many other technologies that have been developed. In addition to presbyopia-correcting IOLs, several options exist for correction by refractive surgery at the corneal ...

Dr. Douglas recommends Systane Complete PF Drops as a reputable brand. These drops offer the whole package: They’re preservative-free, and the active ingredient is propylene glycol, which ...

But through all of this, there has been renewed interest in presbyopia — what is it, and whom does it affect? Presbyopia, states the Mayo Clinic’s website, is the gradual loss of your eyes ...

If you find yourself squinting at menus or turning up the brightness to try and read texts on your phone, you might have presbyopia. And you're not alone. After age 40, nearly every person will ...

This condition, called presbyopia, affects near vision and often requires reading glasses. It typically starts in the middle age. "PresVu is essentially a lower-concentration pilocarpine ...

Entod Pharmaceuticals has unveiled PresVu, India's first eye drop developed to lessen dependence on reading glasses for those with presbyopia. Affecting people over 40, this condition hampers the ...

The Drug Controller General of India, India's drug regulatory authority, has approved a novel treatment aimed at relieving millions of people with presbyopia—a common age-related vision ...